© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts
aDepartment of Pharmacology, Cardiovascular Research Institute Maastricht (CARIM), Universiteit Maastricht, Maastricht, The Netherlands
bPathology, Cardiovascular Research Institute Maastricht (CARIM), Universiteit Maastricht, Maastricht, The Netherlands
* Corresponding author. Tel.: +31 (43) 388 1417; Fax: +31 (43) 367 0940; E-mail: hnel@lmib.azm.nl
Objectives: Cardiac remodeling due to myocardial infarction (MI) includes myocyte hypertrophy, collagen deposition, a rise in DNA synthesis, and normalization of initially diminished maximal coronary bloodflow. Previously, we demonstrated that early captopril treatment can prevent the rise in total DNA synthesis, collagen deposition and hypertrophy. In the present experiments, we investigated the effects of captopril or perindoprilat treatment on cardiac endothelial cell proliferation and maximal coronary flow. Methods: MI was induced by ligation of the left coronary artery in Wistar rats. Sham-operated and infarcted rats were treated with captopril (12 mg/kg.d s.c.) from either day 0–21 (early) or day 21–35 (late) after surgery. In isolated retrogradely perfused rat hearts, maximal coronary flow was determined following maximal dilatation with nitroprusside and adenosine (1 mM each). In separate groups, sections of hearts of sham-operated and MI rats treated with BrdU (day 7–14) and either captopril or perindoprilat (1 mg/kg.d s.c.; day 0–14) were double stained with a monoclonal anti-BrdU antibody and the lectin GSI. The total fraction of DNA synthesizing cells and its proportion of endothelial cells was determined. Results: Maximal coronary flow was completely normalized in MI hearts within three weeks after surgery. Early captopril, but not late captopril, inhibited the normalization of maximal coronary flow in MI hearts (Early: sham, 27.4±1.0; MI, 21.2±1.4 ml/min; P<0.05; mean±SEM) without affecting the hypertrophic response. The total fraction of DNA synthesizing cells was significantly increased in MI hearts (sham: 7.6±1.9; MI: 14.9±2.2%). The proportion of endothelial cells, however, was comparable in sham-operated and infarcted hearts (sham: 30±3; MI: 33±3%). Both early captopril and perindoprilat treatment inhibited total DNA synthesis in MI hearts. Only in captopril pre-treated hearts, this inhibition was associated with a disproportionate inhibition of the endothelial cell proliferation (10.3±2.0%). Conclusion: Early captopril treatment inhibits endothelial cell proliferation and coronary vessel growth following MI, which seems to be partly due to inhibition of the renin angiotensin system.
KEYWORDS Rat; Myocardial infarction; Captopril; Perindoprilat; Endothelial cells; Coronary blood vessels
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. I. Dedkov, W. Zheng, and R. J. Tomanek Compensatory growth of coronary arterioles in postinfarcted heart: regional differences in DNA synthesis and growth factor/receptor expression patterns Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1686 - H1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Westendorp, R. G. Schoemaker, H. Buikema, F. Boomsma, D. J. van Veldhuisen, and W. H. van Gilst Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction Eur J Heart Fail, March 1, 2006; 8(2): 122 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Westendorp, R. G. Schoemaker, H. Buikema, D. de Zeeuw, F. Boomsma, W. H. van Gilst, and D. J. van Veldhuisen Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril Eur J Heart Fail, December 1, 2005; 7(7): 1085 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van der Meer, E. Lipsic, R. H. Henning, K. Boddeus, J. van der Velden, A. A. Voors, D. J. van Veldhuisen, W. H. van Gilst, and R. G. Schoemaker Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats With Heart Failure After Myocardial Infarction J. Am. Coll. Cardiol., July 5, 2005; 46(1): 125 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Westendorp, R. G Schoemaker, H. Buikema, D. de Zeeuw, D. J van Veldhuisen, and W. H van Gilst Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 27 - 32. [Abstract] [PDF] |
||||
![]() |
R. Van Kerckhoven, R. van Veghel, P. R Saxena, and R. G Schoemaker Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts Cardiovasc Res, February 15, 2004; 61(3): 620 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. de Boer, Y. M. Pinto, A. J.H. Suurmeijer, S. Pokharel, E. Scholtens, M. Humler, J. M. Saavedra, F. Boomsma, W. H. van Gilst, and D. J. van Veldhuisen Increased expression of cardiac angiotensin II type 1 (AT1) receptors decreases myocardial microvessel density after experimental myocardial infarction Cardiovasc Res, February 1, 2003; 57(2): 434 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Palmen, M.J.A.P. Daemen, R. Bronsaer, W.R.M. Dassen, H.R. Zandbergen, M. Kockx, J.F.M. Smits, R. van der Zee, and P.A. Doevendans Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice Cardiovasc Res, June 1, 2001; 50(3): 516 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Van Kerckhoven, E. A.J Kalkman, P. R Saxena, and R. G Schoemaker Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts Cardiovasc Res, May 1, 2000; 46(2): 316 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.M Cleutjens, W.M. Blankesteijn, M. J.A.P Daemen, and J. F.M Smits The infarcted myocardium: Simply dead tissue, or a lively target for therapeutic interventions Cardiovasc Res, November 1, 1999; 44(2): 232 - 241. [Full Text] [PDF] |
||||




